Research Nester Logo.jpg
Germ Cell Tumor Market revenue to hit USD 122 Billion by 2035, says Research Nester
November 21, 2023 06:30 ET | Research Nester
New York, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global germ cell tumor market size is projected to grow at a CAGR of over 12% from 2024-2036. The market is expected to garner a revenue of USD 122...
IIA Logo_Segment-Beauty.png
SBLA BEAUTY Eye Lift Wand Recognized With “Eye Treatment Product Of The Year ” Award From Beauty Innovation
November 15, 2023 08:00 ET | Beauty Innovation Awards
LOS ANGELES, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The 2023 Beauty Innovation Awards today announced that the Eye Lift Wand from SBLA BEAUTY has been selected as “Eye Treatment Product Of The Year” in...
Research Nester Logo.jpg
Mucous Membrane Decontamination Market revenue to surpass USD 15 Billion by 2035, says Research Nester
September 26, 2023 05:00 ET | Research Nester
New York, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The global mucous membrane decontamination market size is slated to expand at ~15% CAGR between 2023 and 2035. The market is poised to garner a revenue...
MicrosoftTeams-image (5).png
Radiation Dermatitis Market Set to Expand at 5% CAGR, Targeting USD 700 Mn by 2030, States TMR Study
June 13, 2023 08:30 ET | Transparency Market Research
Wilmington, Delaware, United States, June 13, 2023 (GLOBE NEWSWIRE) -- The global radiation dermatitis market stood at USD 400 Mn in 2019 and is projected to reach a value of USD 700 Mn by 2030. ...
Contrive Datum Insights_Logo.jpg
The Acne Medicine Market is Projected To Reach USD 10.8 billion By 2030, From USD 6.1 billion in 2022,Registering a CAGR Of 7.40% During The Forecast Period 2023-2030| Data By Contrive Datum Insights Pvt Ltd.
May 11, 2023 17:00 ET | Contrive Datum Insights Pvt Ltd
Farmington, May 11, 2023 (GLOBE NEWSWIRE) -- The Global Acne Medicine market size was valued at USD 6.1 billion in 2022 and is projected to reach USD 10.8 billion by 2030, growing at a CAGR of 7.40%...
Analgesics Market GNW_11zon.jpg
Analgesics Market to Reach USD 56.86 Million by 2030, States a New Report by Next Move Strategy Consulting
February 09, 2023 09:00 ET | Next Move Strategy Consulting
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the Global Analgesics Market is estimated to be USD 35.03 million in 2021 and is...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals’ Multi-Target Topical Drug Produces Positive Results in Preclinical Study in Acne
January 09, 2023 10:00 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health, is pleased to announce that in a...
GMILogo_Vertical-Gradient.png
Acne Medication Market worth USD 17.5 Billion by 2032, Says Global Market Insights Inc.
November 28, 2022 05:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The acne medication market value is set to surpass USD 17.5 billion by 2032, according to a new research report by Global Market Insights...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals, Inc. reports positive preclinical data in melanoma and squamous cell carcinoma, initiates a program aimed at advancing topical therapies for skin cancer to the clinic
October 12, 2022 10:00 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy aging, has...
researchdrivelogo.jpg
Global Radiodermatitis Market Anticipated to Generate a Revenue of $561.7 Million and Rise at a CAGR of 4.1% during the Forecast Timeframe 2021-2028 | Approved [169-Pages] by Research Dive
August 29, 2022 09:08 ET | Research Dive
New York, USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global radiodermatitis market is envisioned to garner a revenue of $561.7 million and grow at a...